🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Himanshu Nagar

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-2381-6910
MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.1Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.29760
Top 25%
0.816DataRank
Top 25%20 citations

Lhaden Tshering, Xiaoyue Ma, Jim C. Hu, Christopher E. Barbieri, Timothy McClure +2 more

Papers

Driven by 16 papers — median percentile 58. Top paper: “68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study”.

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

Translational Oncology(2021)10.1016/j.tranon.2021.101242
N/A
1.2DataRank · unranked
18 citations

Kritika Subramanian, Daniel Margolis, Elisabeth O’Dwyer, Joseph R. Osborne, Yuliya Jhanwar +7 more

Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.29760
Top 25%
0.816DataRank
Top 25%20 citations

Lhaden Tshering, Xiaoyue Ma, Jim C. Hu, Christopher E. Barbieri, Timothy McClure +2 more

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4604
N/A
0.464DataRank · unranked
21 citations

Theodore Karrison, Bradley A. McGregor, Pedro C. Barata, Himanshu Nagar, Chad Tang +10 more

Phase I/II study of 225Ac-J591 plus 177Lu-PSMA-I&T for progressive metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5100
N/A
0.269DataRank · unranked
5 citations

Joseph R. Osborne, Peter Gregos, Charlene Thomas, Mahelia Bissassar, Sharon Singh +14 more

A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution

European Urology Oncology(2025)10.1016/j.euo.2025.05.014
N/A
0.269DataRank · unranked
5 citations

Marshall A. Diven, Brady Rippon, Christopher E. Barbieri, Jim C. Hu, Douglas S. Scherr +20 more

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161
Top 60%
0.250DataRank
Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.37165
N/A
0DataRank · unranked
14 citations

Marshall A. Diven, Xiaoyue Ma, Ariel E. Marciscano, Jim C. Hu, Tim D. McClure +3 more

Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad018
N/A
0DataRank · unranked
2 citations

Michael Tzeng, Ashwin Ramaswamy, Xiangmei Gu, Meenakshi Davuluri, Himanshu Nagar +2 more

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps589
N/A
0DataRank · unranked
1 citations

Karla V. Ballman, Scott T. Tagawa, Alan Tan, Bishoy M. Faltas, Arshin Sheybani +11 more

PrecisionPro Fusion: Clinical validation of an automated, rigid, Prostate-Specific MRI-CT Fusion system for prostate radiotherapy planning

Technical Innovations & Patient Support in Radiation Oncology(2025)10.1016/j.tipsro.2025.100353
N/A
0DataRank · unranked
0 citations

Christopher C. Conlin, Madison Baxter, John P. Christodouleas, Robert T. Dess, I. Dragojević +12 more

Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group

European Urology(2025)10.1016/j.eururo.2025.11.013
N/A
0DataRank · unranked
0 citations

Samson W. Fine, Jorg R. Oddens, Auke Jager, Arnoud W. Postema, Harrie P. Beerlage +86 more

An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.12.005
N/A
0DataRank · unranked
12 citations

Nicholas G. Zaorsky, H.P. Bagshaw, Alejandro Berlín, Alison Tree, Sandra Turner +21 more

Evolving Trends in the Management of Low-Risk Prostate Cancer

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.004
N/A
0DataRank · unranked
9 citations

Spyridon P. Basourakos, Meenakshi Davuluri, Himanshu Nagar, Ashwin Ramaswamy, Emily Cheng +3 more

Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis

European Urology Oncology(2023)10.1016/j.euo.2023.04.004
N/A
0DataRank · unranked
42 citations

Xian Wu, Alexander J. Hill, Donald G. Brennan, Danly Omil-Lima, Spyridon P. Basourakos +14 more

Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation

Radiation Oncology(2023)10.1186/s13014-023-02375-5
N/A
0DataRank · unranked
23 citations

Asona Lui, Matthew S. Katz, Alejandro Berlín, Sophia C. Kamran, Amar U. Kishan +7 more

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men

Scientific Reports(2023)10.1038/s41598-023-35567-w
N/A
0DataRank · unranked
16 citations

J Gil Martínez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson +5 more